Trials / Unknown
UnknownNCT03175952
Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Tianjin Chest Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study is a prospective cohort study conducted in Tianjin Chest Hospital, China. Patients with saphenous vein graft disease after coronary artery bypass graft, and planning for receiving percutaneous coronary intervention after virtual histology intravascular ultrasound will be enrolled between May 2017 and April 2019. These subjects will be followed up at 1, 6 and 12 months post-operation of PCI to assess the short-term and long-term effect.
Conditions
- Major Adverse Cardiovascular Events
- Saphenous Vein Graft Disease
- Virtual Histology Intravascular Ultrasound
- Percutaneous Coronary Intervention
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | virtual histology intravascular ultrasound | Patients with saphenous vein graft disease will be examined using virtual histology intravascular ultrasound, and treated with percutaneous coronary intervention. Then they will be followed up at 1, 6 and 12 months. |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2019-04-30
- Completion
- 2020-05-01
- First posted
- 2017-06-05
- Last updated
- 2017-09-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03175952. Inclusion in this directory is not an endorsement.